Shares of Audentes Therapeutics, Inc. (NASDAQ:BOLD) have generated a 1-year price change of -23.12%. However, a year is a very long time in the capital markets arena, so let’s take a look at some more recent price performance. This stock has seen its price move by 12.14% in the past week, and it has experienced a price shift of 10.18% over the past month.
How is this company’s stock performing right now? This publicly-traded organization’s shares demonstrated a change of 4.78% during most recent session, ending the trading day priced at $25.87 with a 24-hour trading volume that reached 1.12 million – compared to its average trading volume of as 692.58K, as recorded over the past three months. With that closing price, the market capitalization of this company is now sitting at $1.05B.
At the time of writing, Audentes Therapeutics, Inc..has a P/B values of 3.11. The current distance from this particular stock’s 20 days simple moving average is 18.11%, while it is 9.26% from its 50 days simple moving average and -21.56% from its recorded 200 days simple moving average. Additionally, this stock’s distance from its 52-week high price is currently -43.98%, while it’s sitting 44.12% away from its 52-week low price.
In the investing world, the current ratio and the debt ratio are two metrics that demonstrate to potential buyers of a stock how fast the company is able to pay down the debt that it owes and just how soon it can fully take care of all its present dues. At the present moment, the current ratio of BOLD is at 14.80 while its debt ratio is 0.00.
A public company’s share value can be further analyzed by looking at its EPS growth rate, which Wall Street analysts use to project its 5-year EPS growth rate. For Audentes Therapeutics, Inc. (NASDAQ:BOLD), analysts are expecting its 5-year EPS growth rate to be 3.90%.
While considering a stock buy, it’s wise to consider what the average Wall Street analyst’s current price target is for each potential investment. It provides us with an idea of where certain stocks’ price paths are expected to go in the near future. At the moment, the price target set for BOLD is $38.64. It’s also helpful to look at the average analyst recommendation score – which is provided on a scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is a strong sell. Right now, the average analyst recommendation for BOLD stands at 2.20, which indicates that analysts recommend investors Buy their shares of BOLD.
Traders use the ATR to analyze potential exit and entry points, as it is a useful tool to add into any trading technique. ATR for this stock is sitting at 1.63. Beta tells us about a stock’s volatility, also known as its systematic risk, compared to the market overall. For the past 7-day period, this stock’s volatility was 7.01%, while it was 7.73% for the past 30-day period.
Professionals on Wall Street also frequently check the Relative Strength Index (RSI) of a potential investment, which tells us the speed and change of a stock’s price path. This RSI is expressed on a scale of 0 to 100. If it is higher than 70, then it’s overbought, while it’s oversold if it is below 30. Right now, BOLD has an RSI of 65.30.